These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16899222)
21. Expression and regulation of adiponectin and receptor in human and rat placenta. Caminos JE; Nogueiras R; Gallego R; Bravo S; Tovar S; García-Caballero T; Casanueva FF; Diéguez C J Clin Endocrinol Metab; 2005 Jul; 90(7):4276-86. PubMed ID: 15855268 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of 5 alpha-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone. Thomas LN; Douglas RC; Rittmaster RS; Too CK Prostate; 2009 May; 69(6):595-602. PubMed ID: 19125422 [TBL] [Abstract][Full Text] [Related]
23. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer. Das S; Roth CP; Wasson LM; Vishwanatha JK Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178 [TBL] [Abstract][Full Text] [Related]
24. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines. Chow L; Rezmann L; Imamura K; Wang L; Catt K; Tikellis C; Louis WJ; Frauman AG; Louis SN Prostate; 2008 May; 68(6):651-60. PubMed ID: 18288685 [TBL] [Abstract][Full Text] [Related]
25. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. König JE; Senge T; Allhoff EP; König W Prostate; 2004 Feb; 58(2):121-9. PubMed ID: 14716737 [TBL] [Abstract][Full Text] [Related]
26. Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline. Hsieh JT; Wu HC; Gleave ME; von Eschenbach AC; Chung LW Cancer Res; 1993 Jun; 53(12):2852-7. PubMed ID: 7684949 [TBL] [Abstract][Full Text] [Related]
27. Adiponectin receptor 2 is regulated by nutritional status, leptin and pregnancy in a tissue-specific manner. González CR; Caminos JE; Gallego R; Tovar S; Vázquez MJ; Garcés MF; Lopez M; García-Caballero T; Tena-Sempere M; Nogueiras R; Diéguez C Physiol Behav; 2010 Jan; 99(1):91-9. PubMed ID: 19887079 [TBL] [Abstract][Full Text] [Related]
28. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer. Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454 [TBL] [Abstract][Full Text] [Related]
29. Regulation of growth hormone receptors in human prostate cancer cell lines. Bidosee M; Karry R; Weiss-Messer E; Barkey RJ Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305 [TBL] [Abstract][Full Text] [Related]
31. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417 [TBL] [Abstract][Full Text] [Related]
32. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Tørring N; Jørgensen PE; Sørensen BS; Nexø E Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639 [TBL] [Abstract][Full Text] [Related]
33. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells. Golovko O; Nazarova N; Tuohimaa P Life Sci; 2005 Jun; 77(5):562-77. PubMed ID: 15904673 [TBL] [Abstract][Full Text] [Related]
34. Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer. Sidiropoulos M; Chang A; Jung K; Diamandis EP Br J Cancer; 2001 Aug; 85(3):393-7. PubMed ID: 11487271 [TBL] [Abstract][Full Text] [Related]
35. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells. Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440 [TBL] [Abstract][Full Text] [Related]
36. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Subbarayan V; Sabichi AL; Llansa N; Lippman SM; Menter DG Cancer Res; 2001 Mar; 61(6):2720-6. PubMed ID: 11289153 [TBL] [Abstract][Full Text] [Related]
37. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
38. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity. Gao AC; Lou W; Isaacs JT Cancer Res; 1998 Apr; 58(7):1391-4. PubMed ID: 9537237 [TBL] [Abstract][Full Text] [Related]
39. Human agonistic antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 induces cytotoxicity and apoptosis in prostate cancer and bladder cancer cells. Shimada O; Wu X; Jin X; Nouh MA; Fiscella M; Albert V; Matsuda T; Kakehi Y Urology; 2007 Feb; 69(2):395-401. PubMed ID: 17320696 [TBL] [Abstract][Full Text] [Related]
40. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Arditi JD; Venihaki M; Karalis KP; Chrousos GP Horm Metab Res; 2007 Jan; 39(1):9-13. PubMed ID: 17226107 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]